Squamous Cell Carcinomas
Squamous Cell Carcinomas (SCC) are a type of cancer that usually starts in the cells of the skin or within the body's mucous membranes, such as the lining of the lungs, throat, or digestive tract. SCC is responsible for approximately 1 in 5 skin cancers. Researchers in the fields of Hematology and Oncology have been studying SCC to understand this cancer's biology, its genetic background, and the development of effective treatments. The current research focuses mainly on the molecular and genetic pathways that lead to the development of SCC. The most common cause of SCC is exposure to ultraviolet (UV) radiation from the sun or tanning beds. Other risk factors for SCC include a family history of skin cancer, a weakened immune system, exposure to certain chemicals, radiation therapy, or chronic skin damage, such as scars or burns. Hematology and Oncology research has primarily focused on the development of advanced diagnostic tools and treatments for SCC. This work has led to the discovery of various therapeutic approaches, including surgical removal of tumors, targeted therapies that block specific proteins or pathways, and immunotherapy that harnesses the body's immune system to destroy cancer cells. In conclusion, Hematology and Oncology research have made significant advancements in the diagnosis and treatment of SCC. The ongoing efforts of these researchers hold tremendous promise for improving the lives of those affected by SCC and to promote better health outcomes against cancers that are currently challenges in the healthcare sector.
← Hematology Research and Oncology Research